Published in Am J Clin Pathol on January 01, 1998
Detection of chromosomal translocations in leukemia. Is there a best way? Am J Clin Pathol (1998) 0.78
TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis. Leukemia (2009) 4.53
Lymphoid neogenesis in rheumatoid synovitis. J Immunol (2001) 3.63
Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML. Leukemia (2009) 3.23
Low JAK2V617F allele burden in primary myelofibrosis, compared to either a higher allele burden or unmutated status, is associated with inferior overall and leukemia-free survival. Leukemia (2008) 3.04
FIP1L1-PDGFRA in eosinophilic disorders: prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature. Leuk Res (2006) 2.41
Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma. Leukemia (2003) 2.28
ICSH recommendations for the measurement of haemoglobin A2. Int J Lab Hematol (2011) 2.23
CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia. Leukemia (2013) 2.11
Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia. Br J Haematol (2001) 2.10
Primary renal non-Hodgkin's lymphoma. An unusual extranodal site. Cancer (1995) 1.82
True T-cell chronic lymphocytic leukemia: a morphologic and immunophenotypic study of 25 cases. Blood (1995) 1.81
Sclerosing extramedullary hematopoietic tumor in chronic myeloproliferative disorders. Am J Surg Pathol (2000) 1.79
Monosomal karyotype in myelodysplastic syndromes, with or without monosomy 7 or 5, is prognostically worse than an otherwise complex karyotype. Leukemia (2010) 1.79
Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas. Leukemia (2008) 1.75
Cytogenetic analysis of six renal oncocytomas and a chromophobe cell renal carcinoma. Evidence that -Y, -1 may be a characteristic anomaly in renal oncocytomas. Cancer Genet Cytogenet (1992) 1.73
Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes. Leukemia (2013) 1.69
The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis. Blood (1985) 1.67
Dual color fluorescence in situ hybridization to investigate aneuploidy in sperm from 33 normal males and a man with a t(2;4;8)(q23;q27;p21) Fertil Steril (1994) 1.54
Pure red cell aplasia: association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities. Blood (1996) 1.53
Clinicopathologic, immunophenotypic, and molecular characterization of primary cutaneous follicular B-cell lymphoma. Arch Dermatol (2001) 1.53
Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas. Leukemia (2008) 1.51
Measurement of blood volume and red cell mass: re-examination of 51Cr and 125I methods. Blood Cells Mol Dis (1996) 1.51
Small B-cell lymphoid neoplasms with coexisting T-cell lymphomas. Am J Clin Pathol (1992) 1.51
The role of CD8+ CD40L+ T cells in the formation of germinal centers in rheumatoid synovitis. J Immunol (1998) 1.50
SF3B1 mutations in primary myelofibrosis: clinical, histopathology and genetic correlates among 155 patients. Leukemia (2011) 1.48
SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMML. Leukemia (2013) 1.48
Symptomatic gastric amyloidosis in patients with primary systemic amyloidosis. Mayo Clin Proc (1993) 1.47
Ectopic lymphoid organogenesis: a fast track for autoimmunity. Am J Pathol (2001) 1.46
Primary lymph node presentation of angiocentric lymphoma associated with features of a hemophagocytic syndrome. Am J Hematol (1989) 1.44
Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas. Am J Surg Pathol (2001) 1.44
WHO-defined chronic neutrophilic leukemia: a long-term analysis of 12 cases and a critical review of the literature. Leukemia (2005) 1.44
Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera. Leukemia (2007) 1.42
Malignant lymphoma of the bladder: evidence from 36 cases that low-grade lymphoma of the MALT-type is the most common primary bladder lymphoma. Am J Surg Pathol (1997) 1.42
Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: role of malignant stromal macrophages. Blood (1995) 1.41
Megaloblastic pancytopenia associated with dapsone and trimethoprim treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Arch Intern Med (1989) 1.40
Lymphocytic infiltrates of the skin in association with cyclosporine therapy. J Am Acad Dermatol (1990) 1.39
Diagnostic utility of fluorescence in situ hybridization in mantle-cell lymphoma. Br J Haematol (2000) 1.38
Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia. Blood (2000) 1.36
Differential prognostic effect of IDH1 versus IDH2 mutations in myelodysplastic syndromes: a Mayo Clinic study of 277 patients. Leukemia (2011) 1.35
WHO-defined 'myelodysplastic syndrome with isolated del(5q)' in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutations. Leukemia (2010) 1.34
A novel three-color, clone-specific fluorescence in situ hybridization procedure for monoclonal gammopathies. Cancer Genet Cytogenet (1998) 1.34
Laryngeal amyloidosis: a clinicopathologic and immunohistochemical review. Otolaryngol Head Neck Surg (1992) 1.32
B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules. Leukemia (2002) 1.32
Orbital lymphoma: radiotherapy outcome and complications. Radiother Oncol (2001) 1.31
Validation of immunoglobulin gene rearrangement detection by PCR using commercially available BIOMED-2 primers. Leukemia (2006) 1.27
Bone marrow JAK2V617F allele burden and clinical correlates in polycythemia vera. Leukemia (2007) 1.27
Physical mapping of a translocation breakpoint in neurofibromatosis. Science (1989) 1.27
Analysis of the unique hamster cell tropism of ecotropic murine leukemia virus PVC-211. J Virol (1996) 1.25
Primary spinal epidural non-Hodgkin's lymphoma: report of eight patients and review of the literature. Neurosurgery (1992) 1.24
Imaging, dosimetry, and radioimmunotherapy with iodine 131-labeled anti-CD37 antibody in B-cell lymphoma. J Clin Oncol (1992) 1.22
Type C viral gag gene expression in chicken embryo fibroblasts and avian sarcoma virus-transformed mammalian cells. J Virol (1977) 1.18
Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia. Br J Haematol (2001) 1.17
Chronic neutrophilic leukemia (CNL): a clinical, pathologic and cytogenetic study. Leukemia (2001) 1.17
Myoepitheliomas in inbred laboratory mice. Vet Pathol (1991) 1.16
Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia. Br J Haematol (2005) 1.16
Posttransplant primary CNS lymphoma. Neuro Oncol (2000) 1.16
Theory and applications of the polymerase chain reaction. Am J Clin Pathol (1990) 1.15
Fine-needle aspiration and immunophenotyping. A role in diagnostic hematopathology? Am J Clin Pathol (1994) 1.14
Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia. Blood (1986) 1.12
A tdic(5;15)(p31;p11) chromosome showing variation for constriction in the centromeric regions in a patient with the cri du chat syndrome. Cytogenet Cell Genet (1979) 1.12
The efficacy of direct, 24-hour culture, and mitotic synchronization methods for cytogenetic analysis of bone marrow in neoplastic hematologic disorders. Cancer Genet Cytogenet (1985) 1.12
Idiopathic thrombocytopenic purpura associated with breast cancer: a case report and review of the current literature. Am J Clin Oncol (1999) 1.12
Effects of subtle changes in the SU protein of ecotropic murine leukemia virus on its brain capillary endothelial cell tropism and interference properties. Virology (1996) 1.12
Chromosomally abnormal clones and nonrandom telomeric translocations in cardiac myxomas. Mayo Clin Proc (1987) 1.11
A cytogenetic study of 53 human gliomas. Cancer Genet Cytogenet (1989) 1.11
The (11;14)(q13;q32) translocation in multiple myeloma. A morphologic and immunohistochemical study. Am J Clin Pathol (2000) 1.10
Vertebral osteoporosis in ankylosing spondylitis. Clin Orthop Relat Res (1971) 1.09
Frequent occurrence of cytogenetic abnormalities in sporadic nonmedullary thyroid carcinoma. Cancer (1990) 1.09
Novel multi-parameter flow cytometry sensitively detects phenotypically distinct plasma cell subsets in plasma cell proliferative disorders. Leukemia (2007) 1.08
Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL. Leukemia (2011) 1.07
Long-term amphotericin B therapy for disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med (1989) 1.07
Lenalidomide therapy in del(5)(q31)-associated myelofibrosis: cytogenetic and JAK2V617F molecular remissions. Leukemia (2007) 1.06
Lymphomatoid granulomatosis. Evidence of immunophenotypic diversity and relationship to Epstein-Barr virus infection. Am J Surg Pathol (1995) 1.06
Mapping studies and expression of genes located on human chromosome 11, band q23. Cytogenet Cell Genet (1988) 1.05
Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myeloma. Cancer Genet Cytogenet (1999) 1.05
A bone marrow report of absent stainable iron is not diagnostic of iron deficiency. Ann Hematol (2001) 1.05
Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy. Leukemia (2001) 1.04
The JAK2 46/1 haplotype confers susceptibility to essential thrombocythemia regardless of JAK2V617F mutational status-clinical correlates in a study of 226 consecutive patients. Leukemia (2009) 1.04
Epstein-Barr virus--determined clonality in posttransplant lymphoproliferative disease. Transplantation (1990) 1.04
Neurological complications of peripheral and cutaneous T-cell lymphomas. Ann Neurol (1994) 1.03
Concurrent eosinophilic fasciitis and cutaneous T-cell lymphoma. Eosinophilic fasciitis as a paraneoplastic syndrome of T-cell malignant neoplasms? Arch Dermatol (1991) 1.03
Apparent irreversible H2-receptor blocking and prolonged gastric antisecretory activities of 3-N-(3-[3-(1-piperidinomethyl)phenoxy]propyl) amino-4-amino-1,2,5-thiadiazole-1-oxide (L-643, 441). J Pharmacol Exp Ther (1983) 1.03
Cytogenetic studies in 174 consecutive patients with preleukemic or myelodysplastic syndromes. Mayo Clin Proc (1985) 1.02